These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33331657)

  • 1. Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity.
    Cizmecioglu A; Akay Cizmecioglu H; Goktepe MH; Emsen A; Korkmaz C; Esenkaya Tasbent F; Colkesen F; Artac H
    J Med Virol; 2021 May; 93(5):2867-2874. PubMed ID: 33331657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.
    Yang Y; Kuang L; Li L; Wu Y; Zhong B; Huang X
    J Infect Dis; 2021 Oct; 224(8):1333-1344. PubMed ID: 34374752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.
    Jafarzadeh A; Jafarzadeh S; Nozari P; Mokhtari P; Nemati M
    Scand J Immunol; 2021 Feb; 93(2):e12967. PubMed ID: 32875598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes.
    Xie L; Lin Y; Deng Y; Lei B
    Viral Immunol; 2021; 34(6):416-420. PubMed ID: 33902347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.
    Thompson EA; Cascino K; Ordonez AA; Zhou W; Vaghasia A; Hamacher-Brady A; Brady NR; Sun IH; Wang R; Rosenberg AZ; Delannoy M; Rothman R; Fenstermacher K; Sauer L; Shaw-Saliba K; Bloch EM; Redd AD; Tobian AAR; Horton M; Smith K; Pekosz A; D'Alessio FR; Yegnasubramanian S; Ji H; Cox AL; Powell JD
    Cell Rep; 2021 Mar; 34(11):108863. PubMed ID: 33691089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.
    Mahmoodpoor A; Hosseini M; Soltani-Zangbar S; Sanaie S; Aghebati-Maleki L; Saghaleini SH; Ostadi Z; Hajivalili M; Bayatmakoo Z; Haji-Fatahaliha M; Babaloo Z; Farid SS; Heris JA; Roshangar L; Rikhtegar R; Kafil HS; Yousefi M
    Mol Immunol; 2021 Oct; 138():121-127. PubMed ID: 34392110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19.
    Kundura L; Gimenez S; Cezar R; André S; Younas M; Lin YL; Portalès P; Lozano C; Boulle C; Reynes J; Vincent T; Mettling C; Pasero P; Muller L; Lefrant JY; Roger C; Claret PG; Duvnjak S; Loubet P; Sotto A; Tran TA; Estaquier J; Corbeau P
    J Allergy Clin Immunol; 2022 Sep; 150(3):594-603.e2. PubMed ID: 35841981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.
    Martín-Sánchez E; Garcés JJ; Maia C; Inogés S; López-Díaz de Cerio A; Carmona-Torre F; Marin-Oto M; Alegre F; Molano E; Fernandez-Alonso M; Perez C; Botta C; Zabaleta A; Alcaide AB; Landecho MF; Rua M; Pérez-Warnisher T; Blanco L; Sarvide S; Vilas-Zornoza A; Alignani D; Moreno C; Pineda I; Sogbe M; Argemi J; Paiva B; Yuste JR
    Front Immunol; 2021; 12():659018. PubMed ID: 34012444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphopenia in COVID-19: Therapeutic opportunities.
    Fathi N; Rezaei N
    Cell Biol Int; 2020 Sep; 44(9):1792-1797. PubMed ID: 32458561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
    Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
    JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID-19: Implications for disease severity and prognosis.
    Xu X; Huang J; Zhang H; Lu W; Liu J
    Immun Inflamm Dis; 2024 May; 12(5):e1281. PubMed ID: 38780019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity.
    Falck-Jones S; Vangeti S; Yu M; Falck-Jones R; Cagigi A; Badolati I; Österberg B; Lautenbach MJ; Åhlberg E; Lin A; Lepzien R; Szurgot I; Lenart K; Hellgren F; Maecker H; Sälde J; Albert J; Johansson N; Bell M; Loré K; Färnert A; Smed-Sörensen A
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33492309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
    Liu B; Han J; Cheng X; Yu L; Zhang L; Wang W; Ni L; Wei C; Huang Y; Cheng Z
    Sci Rep; 2020 Oct; 10(1):17718. PubMed ID: 33077873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease.
    Peñaloza HF; Lee JS; Ray P
    PLoS Pathog; 2021 Sep; 17(9):e1009850. PubMed ID: 34473802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
    Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
    Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.